Sign In
Buy APYX
$4.10
-0.0200 (-0.485%)
At Close: Jul 31, 2026
Apyx Medical (APYX) Reports Q2 Loss, Lags Revenue Estimates
07:30pm, Thursday, 08'th Aug 2024
Apyx Medical (APYX) came out with a quarterly loss of $0.19 per share versus the Zacks Consensus Estimate of a loss of $0.18. This compares to loss of $0.11 per share a year ago.
Renuvion is the only device FDA-cleared for contracting subcutaneous tissue CLEARWATER, Fla. , June 26, 2024 /PRNewswire/ -- Apyx® Medical Corporation (NASDAQ: APYX) ("Apyx Medical;" the "Company"
Apyx Medical Corporation (APYX) Q1 2024 Earnings Call Transcript
06:33pm, Saturday, 11'th May 2024
Apyx Medical Corporation (NASDAQ:APYX ) Q1 2024 Results Conference Call May 9, 2024 8:00 AM ET Company Participants Charles Goodwin - President, Chief Executive Officer & Director Matt Hill - Chief Fi
Apyx Medical (APYX) Reports Q1 Loss, Tops Revenue Estimates
09:21am, Thursday, 09'th May 2024
Apyx Medical (APYX) came out with a quarterly loss of $0.22 per share versus the Zacks Consensus Estimate of a loss of $0.18. This compares to loss of $0.10 per share a year ago.
Apyx Medical Corporation to Release First Quarter of Fiscal Year 2024 Financial Results on May 9, 2024
07:30am, Thursday, 25'th Apr 2024
CLEARWATER, Fla.--(BUSINESS WIRE)--Apyx Medical Corporation (NASDAQ:APYX) (the “Company”), the manufacturer of a proprietary helium plasma and radiofrequency technology marketed and sold as Renuvi
Apyx Medical Corporation Showcases New Data and Treatment Insights at the Renuvion® Users' Summit
07:30am, Thursday, 11'th Apr 2024
CLEARWATER, Fla.--(BUSINESS WIRE)--Apyx® Medical Corporation (NASDAQ:APYX) (the “Apyx Medical”; “Company”), the manufacturer of a proprietary helium plasma and radiofrequency technology marke
Apyx Medical Corporation (APYX) Q4 2023 Earnings Call Transcript
10:12am, Thursday, 21'st Mar 2024
Apyx Medical Corporation (APYX) Q4 2023 Earnings Call Transcript
Apyx Medical (APYX) Reports Q4 Loss, Tops Revenue Estimates
09:15am, Thursday, 21'st Mar 2024
Apyx Medical (APYX) came out with a quarterly loss of $0.19 per share versus the Zacks Consensus Estimate of a loss of $0.13. This compares to loss of $0.17 per share a year ago.
Apyx Medical Corporation Reports Fourth Quarter and Full Year 2023 Financial Results; Introduces Full Year 2024 Financial Outlook
07:00am, Thursday, 21'st Mar 2024
CLEARWATER, Fla.--(BUSINESS WIRE)--Apyx Medical Corporation (NASDAQ:APYX) (“Apyx Medical;” the “Company”), the manufacturer of a proprietary helium plasma and radiofrequency technology markete
Apyx Medical Corporation to Release Fourth Quarter and Fiscal Year 2023 Financial Results on March 21, 2024
07:30am, Monday, 04'th Mar 2024
CLEARWATER, Fla.--(BUSINESS WIRE)--Apyx® Medical Corporation (NASDAQ:APYX) (the “Company”), the manufacturer of a proprietary helium plasma and radiofrequency technology marketed and sold as Renu
CLEARWATER, Fla.--(BUSINESS WIRE)--Apyx Medical Corporation (Nasdaq: APYX) (“Apyx Medical;” the “Company”), the manufacturer of a proprietary helium plasma and radiofrequency technology market
CLEARWATER, Fla.--(BUSINESS WIRE)--Apyx Medical Corporation (Nasdaq: APYX) (“Apyx Medical;” the “Company”), the manufacturer of a proprietary helium plasma and radiofrequency technology market
Apyx Medical Corporation Reports Preliminary Fourth Quarter and Full Year 2023 Revenue Results
07:00am, Monday, 08'th Jan 2024
CLEARWATER, Fla.--(BUSINESS WIRE)--Apyx Medical Corporation (NASDAQ:APYX) (the “Company”), the manufacturer of a proprietary helium plasma and radiofrequency technology marketed and sold as Renuvi
Apyx Medical Corporation Appoints Matthew Hill as Chief Financial Officer
08:30am, Tuesday, 28'th Nov 2023
CLEARWATER, Fla.--(BUSINESS WIRE)--Apyx Medical Corporation (Nasdaq:APYX) (“Apyx Medical;” the “Company”), the manufacturer of a proprietary helium plasma and radiofrequency technology markete
Apyx Medical Corporation (APYX) Q3 2023 Earnings Call Transcript
11:30am, Thursday, 09'th Nov 2023
Apyx Medical Corporation (NASDAQ:APYX ) Q3 2023 Earnings Conference Call November 9, 2023 8:00 AM ET Company Participants Charles Goodwin - President & CEO Tara Semb - CFO Conference Call Participants
